ribavirin has been researched along with Adenocarcinoma Of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Chen, D; Sun, X; Zhang, X | 1 |
| Kast, RE | 1 |
1 review(s) available for ribavirin and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Carcinoma, Renal Cell; Drug Screening Assays, Antitumor; Hepacivirus; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Models, Biological; Multiple Myeloma; Ribavirin; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin | 2008 |
1 other study(ies) available for ribavirin and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma.
Topics: Animals; Antimetabolites; Apoptosis; Carcinoma, Renal Cell; Cell Proliferation; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Kidney Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Ribavirin; RNA, Small Interfering; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |